Giant Cell Tumor — Trials

Giant Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

52 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07499362	Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)	recruiting	Phase 2	20	Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyINDUSTRY	1	Sep 10, 2026	clinicaltrials
NCT05463796	InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer	recruiting	—	5,000	Dana-Farber Cancer InstituteOTHER	1	Aug 17, 2026	clinicaltrials
NCT06239272	NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)	recruiting	Phase 1 / Phase 2	139	St. Jude Children's Research HospitalOTHER	1	Aug 3, 2026	clinicaltrials

Data updated 19 days agoSource updated Sep 10, 2026source: clinicaltrials